{"id":39,"date":"2024-07-23T07:44:12","date_gmt":"2024-07-23T05:44:12","guid":{"rendered":"https:\/\/www.ipsen.com\/es\/?page_id=39"},"modified":"2025-04-02T17:38:18","modified_gmt":"2025-04-02T15:38:18","slug":"oncologia","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/spain\/oncologia\/","title":{"rendered":"Oncolog\u00eda"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/10\/21111248\/03-1_Sciences-Oncology_Module-Banner_1920X280.jpg)\">\n        <div class=\"container content-sec\" role=\"main\" id=\"main\">\n            <nav aria-label=\"breadcrumb\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/www.ipsen.com\/spain\">Inicio<\/a><\/li><li class=\"breadcrumb-item active\"><a href=\"#\" aria-current=\"page\">\u00c1reas terap\u00e9uticas &#8211; Oncolog\u00eda<\/a><\/li><\/ol>\n            <\/nav>            <h1 class=\"visible\">Oncolog\u00eda<\/h1>\n            <p class=\"visible\">Comprometidos con mejorar la calidad de vida de los pacientes <\/p>\n        <\/div>\n    <\/section>\n\n\n    <section class=\"title-text \">\n        <div class=\"container\">\n            <div class=\"title-text-inner\" style=\"background-color:#DBEAF5;\">\n                <!-- If heading is enabled then it's visible -->\n                <div class=\"text-head-dash visible\">\n                                            <span class=\"dash\"><\/span> \n                        <p class=\"heading-para\">\n                            Nuestro prop\u00f3sito en oncolog\u00eda                         <\/p>\n                                        \n                <\/div>\n\n                <!-- If subtitle is enabled then it's visible -->\n                <div class=\"text-head-dash hidden\">\n                                            <h2 class=\"heading-para\">\n                                                    <\/h2>\n                    \n                <\/div>\n                \n                <!-- If description is enabled then it's visible -->\n                <div class=\"text-parbase visible\">\n                    <p><p>Con m\u00e1s de 35 a\u00f1os de experiencia en oncolog\u00eda, nos gu\u00eda un prop\u00f3sito claro: mejorar la calidad de vida de los pacientes, los resultados de salud y generar un impacto positivo para los pacientes y la sociedad.<\/p>\n<\/p>\n                <\/div>\n\n                <!-- If button is enabled then it's visible -->\n                \n            <\/div>\n        <\/div>\n    <\/section>\n\n\n<!-- Ipsen Content Overlay Start -->\n<section class=\"two-col-image-section\">\n    <div class=\"container two-img-section-innner\">\n                <!-- Ipsen Content Overlay Variation Two Start -->\n                <div class=\"row \">\n                    <div class=\"col-xs-12 col-sm-12 col-md-6 column-1 \">\n                        <div id=\"image-carousel\" class=\"img-video-section carousel\" data-bs-ride=\"carousel\">\n                            <div class=\"carousel-inner\">\n                                                                        <div class=\"carousel-item active\">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/10\/18115849\/05-06_PATIENTS_Text-and-Photos-Overlapped_Ipsen-Crewe-Steve-Pointon_079_STEVE.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                            <\/div>\n                                                    <\/div>\n                    <\/div>\n                    <div class=\" col-xs-12 col-sm-12 col-md-6 column-2 \">\n                        <div class=\" section-content\">\n                                                                                            <h3 class=\"section-head-two\">\n                                        Nuestro compromiso en oncolog\u00eda                                     <\/h3>\n                                                                                            <p class=\"section-para \">\n                                        Nuestro compromiso con la oncolog\u00eda est\u00e1 en el centro de la misi\u00f3n de Ipsen: mejorar la vida de las personas. Nos centramos en tumores complejos y raros, colaborando con socios que comparten nuestros valores y nuestro enfoque innovador.                                    <\/p>\n                                                                                <\/div>\n                    <\/div>\n                    <!-- Ipsen Content Overlay Variation Two End -->\n                <\/div>\n        <!-- Ipsen Content Overlay Variation two End -->\n            <\/div>\n<\/section>\n<!-- Ipsen Content Overlay End -->\n\n<!-- Text & Media Block Code -->\n<section class=\"two-col-section text-media-section\">\n    <div class=\"container two-section-innner section-reverse\">\n        <div class=\"response-inner\" style=\"background-image: url('')\">\n            <div class=\"row section-reverse\">\n                <div class=\"col-xs-12 col-sm-12 col-md-6\">\n                                                    <div class=\"video-embed\"> \n                                <iframe loading=\"lazy\" title=\"IPSEN_Stephen_Mitchell_VOSTVA-maj24--10Mbps\" src=\"https:\/\/player.vimeo.com\/video\/1008011815?app_id=122963&#038;autoplay=1&#038;muted=1&#038;controls=1&#038;loop=1&#038;autopause=1&#038;background=1\" width=\"640\" height=\"360\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" data-ot-ignore><\/iframe>                            <\/div>\t\n                                        <\/div>\n                <div class=\" col-xs-12 col-sm-12 col-md-6\">\n                    <div class=\"section-content\">\n                        <div class=\"heading-dash\">\n                                                    <\/div>\n                        <p class=\"section-head-two\">\n                            Nuestro compromiso con los pacientes                         <\/p>\n                        <p>Recibir un diagn\u00f3stico de c\u00e1ncer cambia la vida y, si bien hay m\u00e1s opciones de tratamiento disponibles que nunca, sigue existiendo una necesidad urgente de innovaci\u00f3n. Por ello, tenemos un firme compromiso de apoyar a los pacientes con algunos de los c\u00e1nceres m\u00e1s dif\u00edciles de tratar. En el \u00e1mbito de la oncolog\u00eda, trabajamos con m\u00e1s de 100 asociaciones de pacientes en todo el mundo apoyando proyectos destinados a promover una mayor conciencia y sensibilidad sobre temas relevantes para la comunidad.<\/p>\n                            <a \n                            aria-label=\"\"  \n                                role=\"link\" \n                                class=\"btn-link section-btn cta-visible\"\n                                href=\"https:\/\/www.ipsen.com\/spain\/pacientes\/\" \n                                target=\"_self\"\n                            > \n                                Saber m\u00e1s \n                            <\/a>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n\n\n\n\n    <!--Accordion Cards Start Here-->\n    <section class=\"accordion\" data-according-id=\"1520393717\">\n        <div class=\"container\">\n            <div class=\"row\">\n                <!--Accordion info section-->\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                    <div class=\"accordian-info\">\n                        <h2 class=\"accordian-heading visible\">Nuestra experiencia en oncolog\u00eda<\/h3>\n                        <p class=\"accordian-summary visible\">Con m\u00e1s de 35 a\u00f1os de experiencia, la oncolog\u00eda representa el \u00e1rea terap\u00e9utica m\u00e1s grande de Ipsen.<\/p>\n                    <\/div>\n                <\/div><!--Accordion info section over here -->\n\n                <div class=\"col-xl-12 col-lg-12 col-md-12 col-sm-12\">\n                    <div class=\"accordion accor-group\" id=\"accordionExample1520393717\">\n                         \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading0\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading15203937170\" aria-expanded=\"false\" aria-controls=\"expHeading15203937170\">\n                                                C\u00e1ncer de pr\u00f3stata                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading15203937170\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading0\" data-bs-parent=\"#accordionExample1520393717\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>El c\u00e1ncer de pr\u00f3stata es el tipo de c\u00e1ncer m\u00e1s frecuente en el var\u00f3n de m\u00e1s de 50 a\u00f1os con aproximadamente 1.467.854<sup>1<\/sup> nuevos casos al a\u00f1o en el mundo, y constituye la quinta causa de muerte por c\u00e1ncer. La incidencia en Espa\u00f1a es de 29.002<sup>2<\/sup> nuevos casos al a\u00f1o, siendo la tercera causa de muerte por c\u00e1ncer. Es una enfermedad heterog\u00e9nea que puede manifestarse con un amplio espectro de agresividad, desde indolente a r\u00e1pidamente progresivo. Antes de la introducci\u00f3n del cribado con PSA en los a\u00f1os 90, muchos hombres presentaban una forma de la enfermedad avanzada, a menudo metast\u00e1sica. El test con PSA facilit\u00f3 la detecci\u00f3n de c\u00e1ncer de pr\u00f3stata en estadios muy precoces.<\/p>\n<p>&nbsp;<\/p>\n<ol>\n<li>Globocan 2022. Disponible <a href=\"https:\/\/gco.iarc.fr\/today\/en\/dataviz\/pie?mode=population&amp;group_populations=0&amp;sexes=1&amp;cancers=27\" target=\"_blank\" rel=\"noopener\"><strong>aqu\u00ed<\/strong><\/a>.(\u00daltimo acceso: julio 2024)<\/li>\n<li>Disponible <strong><a href=\"https:\/\/seom.org\/images\/Las_cifras_del_Cancer_en_Espana_2023.pdf\" target=\"_blank\" rel=\"noopener\">aqu\u00ed<\/a><\/strong>. (\u00daltimo acceso: julio 2024)<\/li>\n<\/ol>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading1\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading15203937171\" aria-expanded=\"false\" aria-controls=\"expHeading15203937171\">\n                                                C\u00e1ncer renal                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading15203937171\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading1\" data-bs-parent=\"#accordionExample1520393717\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>El carcinoma de c\u00e9lulas renales (CCR) es el m\u00e1s frecuente de los c\u00e1nceres renales en adultos, constituyendo aproximadamente el 90% <sup>1<\/sup> de las neoplasias de ri\u00f1\u00f3n. La mayor\u00eda de los tumores se originan en los t\u00fabulos renales proximales &#8211; que forman el sistema de filtraci\u00f3n de los ri\u00f1ones &#8211; y se caracterizan por ser tumores muy vascularizados. Debido a que el c\u00e1ncer de ri\u00f1\u00f3n es asintom\u00e1tico en etapas tempranas, aproximadamente un 30% <sup>2,3<\/sup> de los pacientes presentan enfermedad metast\u00e1sica en el diagn\u00f3stico.<\/p>\n<p>&nbsp;<\/p>\n<ol>\n<li>\u00a0Graves A, Hessamodini H, Wong G, Lim WH. Metastatic renal cell carcinoma: update on epidemiology, getics, and therapeutic modalities. Immunotargets Ther. 2013; 2:73-90.<\/li>\n<li>Gonz\u00e1lez A., Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM). Disponible <a href=\"https:\/\/seom.org\/info-sobre-el-cancer\/renal?start=0\" target=\"_blank\" rel=\"noopener\"><strong>aqu\u00ed<\/strong><\/a>. (\u00daltimo acceso: julio 2024)<\/li>\n<li>Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34(3):193-205.<\/li>\n<\/ol>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading2\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading15203937172\" aria-expanded=\"false\" aria-controls=\"expHeading15203937172\">\n                                                Tumores neuroendocrinos                                             <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading15203937172\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading2\" data-bs-parent=\"#accordionExample1520393717\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Los tumores neuroendocrinos (TNE) se han clasificado como enfermedad rara por las autoridades reguladoras europeas<sup>1<\/sup>. Los TNE constituyen un grupo heterog\u00e9neo, y se definen como neoplasias epiteliales con una diferenciaci\u00f3n predominantemente neuroendocrina. Los m\u00e1s frecuentes son de origen gastrointestinal o pancre\u00e1tico.<\/p>\n<p>&nbsp;<\/p>\n<ol>\n<li>Orphanet: Search a disease. Orpha.net. Disponible <a href=\"https:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?lng=ES&amp;Expert=877\" target=\"_blank\" rel=\"noopener\"><strong>aqu\u00ed<\/strong><\/a>.\u00a0(\u00daltimo acceso: julio 2024)<\/li>\n<\/ol>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading3\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading15203937173\" aria-expanded=\"false\" aria-controls=\"expHeading15203937173\">\n                                                C\u00e1ncer de tiroides                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading15203937173\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading3\" data-bs-parent=\"#accordionExample1520393717\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>El c\u00e1ncer de tiroides es el tumor endocrino maligno m\u00e1s prevalente y su incidencia ha ido en constante aumento durante las \u00faltimas tres d\u00e9cadas. El c\u00e1ncer de tiroides diferenciado (DTC) representa m\u00e1s del 90% <sup>1<\/sup> de todos los c\u00e1nceres de tiroides. Los histotipos dominantes son c\u00e1nceres papilares y foliculares. El carcinoma medular de tiroides es una variedad poco frecuente de c\u00e1ncer de tiroides (5-10 %). Se define como un c\u00e1ncer de la gl\u00e1ndula tiroidea que se origina a partir de las c\u00e9lulas C o parafoliculares localizadas en los fol\u00edculos entre la capa basal y las c\u00e9lulas foliculares.<\/p>\n<p>&nbsp;<\/p>\n<ol>\n<li>Cancer Net. ASCO. Thyroid Cancer: Introduction. Disponible <a href=\"https:\/\/www.cancer.net\/cancer-types\/thyroid-cancer\/introduction\" target=\"_blank\" rel=\"noopener\"><strong>aqu\u00ed<\/strong><\/a>.\u00a0(\u00daltimo acceso: julio 2024)<\/li>\n<\/ol>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading4\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading15203937174\" aria-expanded=\"false\" aria-controls=\"expHeading15203937174\">\n                                                Hepatocarcinoma                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading15203937174\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading4\" data-bs-parent=\"#accordionExample1520393717\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>El c\u00e1ncer de h\u00edgado es el sexto<sup>1<\/sup> c\u00e1ncer m\u00e1s com\u00fan y la segunda causa de muerte m\u00e1s frecuente relacionada con el c\u00e1ncer a nivel mundial. El carcinoma hepatocelular (HCC) representa aproximadamente entre el 70-90 % de los c\u00e1nceres hep\u00e1ticos primarios<sup>2<\/sup>. El HCC aparece predominantemente en pacientes con enfermedad hep\u00e1tica cr\u00f3nica que han desarrollado una cirrosis hep\u00e1tica<sup>3<\/sup>.<\/p>\n<p>&nbsp;<\/p>\n<ol>\n<li>GLOBOCAN 2020.<a href=\"http:\/\/gco.iarc.fr\/\" target=\"_blank\" rel=\"noopener\"><strong>Global Cancer Observatory<\/strong><\/a> \u00a9 International Agency for Research on Cancer 2024. \u00daltimo acceso: julio 2024.<\/li>\n<li>Blachier M, Leleu H, Peck-Radosavljevic M, Valla D-C, Roudot-Thoraval F. The burden of liver disease in Europe: A review of available epidemiological data. J Hepatol. 2013;58(3):593-608.<\/li>\n<li>Reig M, et al. Diagn\u00f3stico y tratamiento del carcinoma hepatocelular. Actualizaci\u00f3n del documento de consenso de la AEEH, AEC, SEOM, SERAM, SERVEI y SETH. Med Clin (Barc). 2020. <a href=\"https:\/\/doi.org\/10.1016\/j.medcli.2020.09.022\" target=\"_blank\" rel=\"noopener\"><strong>Acceder aqu\u00ed<\/strong><\/a>.<\/li>\n<\/ol>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                                                <\/div>\n                <\/div> \n            <\/div>\n        <\/div>\n    <\/section>\n    <!--Accordion Cards End Here-->\n\n\n<!-- Ipsen Content Overlay Start -->\n<section class=\"two-col-image-section\">\n    <div class=\"container two-img-section-innner\">\n                <!-- Ipsen Content Overlay Variation Two Start -->\n                <div class=\"row \">\n                    <div class=\"col-xs-12 col-sm-12 col-md-6 column-1 \">\n                        <div id=\"image-carousel\" class=\"img-video-section carousel\" data-bs-ride=\"carousel\">\n                            <div class=\"carousel-inner\">\n                                                                        <div class=\"carousel-item active\">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/10\/21111424\/Module-9_Oncology-clinical-trial_191209_0729.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                            <\/div>\n                                                    <\/div>\n                    <\/div>\n                    <div class=\" col-xs-12 col-sm-12 col-md-6 column-2 \">\n                        <div class=\" section-content\">\n                                                                                            <h3 class=\"section-head-two\">\n                                        Ensayos cl\u00ednicos en oncolog\u00eda                                    <\/h3>\n                                                                                            <p class=\"section-para \">\n                                        Nos esforzamos constantemente para desarrollar nuevos tratamientos que ofrezcan nuevas respuestas a las necesidades m\u00e9dicas no cubiertas de los pacientes.                                     <\/p>\n                                                                                <\/div>\n                    <\/div>\n                    <!-- Ipsen Content Overlay Variation Two End -->\n                <\/div>\n        <!-- Ipsen Content Overlay Variation two End -->\n            <\/div>\n<\/section>\n<!-- Ipsen Content Overlay End -->\n\n<!-- Ipsen Content Overlay Start -->\n<section class=\"two-col-image-section\">\n    <div class=\"container two-img-section-innner\">\n                <!-- Ipsen Content Overlay Variation Two Start -->\n                <div class=\"row section-bg-reverse\">\n                    <div class=\"col-xs-12 col-sm-12 col-md-6 column-1 order-2\">\n                        <div id=\"image-carousel\" class=\"img-video-section carousel\" data-bs-ride=\"carousel\">\n                            <div class=\"carousel-inner\">\n                                                                        <div class=\"carousel-item active\">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/10\/21111447\/Module-10_Oncology-pipeline_191209_1833.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                            <\/div>\n                                                    <\/div>\n                    <\/div>\n                    <div class=\" col-xs-12 col-sm-12 col-md-6 column-2 order-1\">\n                        <div class=\" section-content\">\n                                                                                            <h3 class=\"section-head-two\">\n                                        Nuestra cartera de productos                                    <\/h3>\n                                                                                            <p class=\"section-para \">\n                                        Colaboramos con otros socios que, como nosotros, tienen el objetivo de desarrollar tratamientos innovadores para personas que se enfrentan a enfermedades complejas. Nuestros equipos se esfuerzan por acelerar la innovaci\u00f3n para ofrecer nuevas opciones de tratamiento a los pacientes que m\u00e1s las necesitan.                                     <\/p>\n                                                                                                <a \n                                            role=\"link\" \n                                            class=\"btn-link section-btn cta-visible\" \n                                            href=\"https:\/\/www.ipsen.com\/pipeline\/\" \n                                            aria-label=\"\" \n                                            target=\"_blank\"\n                                        >\n                                            Saber m\u00e1s                                        <\/a>    \n                                    <\/button>\n                                                    <\/div>\n                    <\/div>\n                    <!-- Ipsen Content Overlay Variation Two End -->\n                <\/div>\n        <!-- Ipsen Content Overlay Variation two End -->\n            <\/div>\n<\/section>\n<!-- Ipsen Content Overlay End -->","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-39","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Comprometidos con mejorar la calidad de vida de los pacientes<\/title>\n<meta name=\"description\" content=\"Nuestros equipos de oncolog\u00eda trabajan incansablemente para desarrollar medicamentos que prolonguen la vida de los pacientes y mejoren sus resultados de salud.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/spain\/oncologia\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Comprometidos con mejorar la calidad de vida de los pacientes\" \/>\n<meta property=\"og:description\" content=\"Nuestros equipos de oncolog\u00eda trabajan incansablemente para desarrollar medicamentos que prolonguen la vida de los pacientes y mejoren sus resultados de salud.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/spain\/oncologia\/\" \/>\n<meta property=\"og:site_name\" content=\"Spain\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-02T15:38:18+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/oncologia\/\",\"url\":\"https:\/\/www.ipsen.com\/spain\/oncologia\/\",\"name\":\"Comprometidos con mejorar la calidad de vida de los pacientes\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#website\"},\"datePublished\":\"2024-07-23T05:44:12+00:00\",\"dateModified\":\"2025-04-02T15:38:18+00:00\",\"description\":\"Nuestros equipos de oncolog\u00eda trabajan incansablemente para desarrollar medicamentos que prolonguen la vida de los pacientes y mejoren sus resultados de salud.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/oncologia\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/spain\/oncologia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/oncologia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/spain\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncolog\u00eda\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#website\",\"url\":\"https:\/\/www.ipsen.com\/spain\/\",\"name\":\"Spain\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/spain\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#organization\",\"name\":\"Spain\",\"url\":\"https:\/\/www.ipsen.com\/spain\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg\",\"caption\":\"Spain\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Comprometidos con mejorar la calidad de vida de los pacientes","description":"Nuestros equipos de oncolog\u00eda trabajan incansablemente para desarrollar medicamentos que prolonguen la vida de los pacientes y mejoren sus resultados de salud.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/spain\/oncologia\/","og_locale":"es_ES","og_type":"article","og_title":"Comprometidos con mejorar la calidad de vida de los pacientes","og_description":"Nuestros equipos de oncolog\u00eda trabajan incansablemente para desarrollar medicamentos que prolonguen la vida de los pacientes y mejoren sus resultados de salud.","og_url":"https:\/\/www.ipsen.com\/spain\/oncologia\/","og_site_name":"Spain","article_modified_time":"2025-04-02T15:38:18+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/spain\/oncologia\/","url":"https:\/\/www.ipsen.com\/spain\/oncologia\/","name":"Comprometidos con mejorar la calidad de vida de los pacientes","isPartOf":{"@id":"https:\/\/www.ipsen.com\/spain\/#website"},"datePublished":"2024-07-23T05:44:12+00:00","dateModified":"2025-04-02T15:38:18+00:00","description":"Nuestros equipos de oncolog\u00eda trabajan incansablemente para desarrollar medicamentos que prolonguen la vida de los pacientes y mejoren sus resultados de salud.","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/spain\/oncologia\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/spain\/oncologia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/spain\/oncologia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/spain\/"},{"@type":"ListItem","position":2,"name":"Oncolog\u00eda"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/spain\/#website","url":"https:\/\/www.ipsen.com\/spain\/","name":"Spain","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/spain\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/spain\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/spain\/#organization","name":"Spain","url":"https:\/\/www.ipsen.com\/spain\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg","caption":"Spain"},"image":{"@id":"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/pages\/39","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/comments?post=39"}],"version-history":[{"count":10,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/pages\/39\/revisions"}],"predecessor-version":[{"id":3166,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/pages\/39\/revisions\/3166"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/media?parent=39"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}